Syncor Corp. to Buy Iodine 123 Business
- Share via
Syncor International Corp., a Chatsworth operator of nuclear pharmacies, said that it has signed a letter of intent with Golden Pharmaceuticals Inc. to buy the company’s Iodine 123 business.
Iodine 123 is used to diagnose thyroid problems.
Previously, Golden was supplying Iodine 123 to Syncor’s network of 130 nuclear pharmacy service centers.
Inside the business of entertainment
The Wide Shot brings you news, analysis and insights on everything from streaming wars to production — and what it all means for the future.
You may occasionally receive promotional content from the Los Angeles Times.
